Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1621 AL 1635

Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias

Shafi S, Singh A, Ibrahim AM, Alhajri N, Abu Izneid T, Pottoo FH.

Eur J Neurosci. 2021 May;53(10):3294-3310. doi: 10.1111/ejn.15215. Epub 2021 Apr 26.

Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration

Lin A, Peiris NJ, Dhaliwal H, Hakim M, Li W, Ganesh S, Ramaswamy Y, Patel S, Misra A.

Cells. 2021 Mar 8;10(3):593. doi: 10.3390/cells10030593.

Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review

Łukasik P, Załuski M, Gutowska I.

Int J Mol Sci. 2021 Mar 13;22(6):2935. doi: 10.3390/ijms22062935.

Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis

Terracciano A, Aschwanden D, Stephan Y, Cerasa A, Passamonti L, Toschi N, Sutin AR.

Mov Disord. 2021 Aug;36(8):1863-1870. doi: 10.1002/mds.28575. Epub 2021 Apr 4.

Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells

Lobine D, Sadeer N, Jugreet S, Suroowan S, Keenoo BS, Imran M, Venugopala KN, Ibrahim FM, Zengin G, Mahomoodally MF.

Curr Neuropharmacol. 2021;19(9):1416-1441. doi: 10.2174/1570159X19666210412095251.

Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation

Lu JY, Sun YM, Yen TC, Zuo CT, Wang J.

Clin Nucl Med. 2021 Sep 1;46(9):e483-e484. doi: 10.1097/RLU.0000000000003674.

Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy

Sarangi SC, Sopory P, Reeta KH.

Neurol India. 2021 Mar-Apr;69(2):252-259. doi: 10.4103/0028-3886.314522.

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches

Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E.

Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.

5-Lipoxygenase as an emerging target against age-related brain disorders

Yan M, Zhang S, Li C, Liu Y, Zhao J, Wang Y, Yang Y, Zhang L.

Ageing Res Rev. 2021 Aug;69:101359. doi: 10.1016/j.arr.2021.101359. Epub 2021 May 10.

Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders

Chalkias IN, Tegos T, Topouzis F, Tsolaki M.

Eur J Ophthalmol. 2021 Nov;31(6):2808-2817. doi: 10.1177/11206721211016311. Epub 2021 May 17.

Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers

Singh AV, Chandrasekar V, Janapareddy P, Mathews DE, Laux P, Luch A, Yang Y, Garcia-Canibano B, Balakrishnan S, Abinahed J, Al Ansari A, Dakua SP.

ACS Chem Neurosci. 2021 Jun 2;12(11):1835-1853. doi: 10.1021/acschemneuro.1c00087. Epub 2021 May 19.

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar D, Sharma A, Flora SJS.

J Biochem Mol Toxicol. 2021 Aug;35(8):e22830. doi: 10.1002/jbt.22830. Epub 2021 May 28.

How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders

Carlson GA, Prusiner SB.

Int J Mol Sci. 2021 May 4;22(9):4861. doi: 10.3390/ijms22094861.

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis

Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L.

Int J Mol Sci. 2021 May 7;22(9):4958. doi: 10.3390/ijms22094958.

Biomarkers for neurodegenerative diseases

Hansson O.

Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias